STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
O
Completed
- Anaplastic Oligoastrocytoma
- +3 more
- Carboplatin
- +7 more
- Minneapolis, Minnesota
- +1 more
2022-03-11
Mar 11, 2022S
Recruiting
- Treatment Refusal
- Gemcitabine
- +3 more
- Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
2020-12-16
Dec 16, 2020S
Active, not recruiting
- Non-Hodgkin's Lymphoma
- Bendamustine
- +6 more
- Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-03
Jun 3, 2021S
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Ruxolitinib
- +2 more
- Phoenix, Arizona
- +5 more
2022-02-11
Feb 11, 2022S
Recruiting
- Recurrent Adult Acute Myeloid Leukemia
- +2 more
- Sirolimus
- +3 more
- Philadelphia, PennsylvaniaThomas Jefferson University
2020-12-07
Dec 7, 2020A
Completed
- Acute Myeloid Leukemia
- Crenolanib besylate
- +7 more
- Houston, TexasMD Anderson Cancer Center
2020-07-17
Jul 17, 2020C
Active, not recruiting
- Brain and Central Nervous System Tumors
- +10 more
- carboplatin
- +9 more
- Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
2021-03-08
Mar 8, 2021W
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
- Saint Louis, MissouriWashington University School of Medicine
2022-03-15
Mar 15, 2022T
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- Myelogenous Leukemia, Acute, Childhood
- AC220
- +3 more
- Los Angeles, California
- +10 more
2022-03-24
Mar 24, 2022S
Active, not recruiting
- Rhabdomyosarcoma
- Vincristine
- +15 more
- Jacksonville, Florida
- +3 more
2021-07-01
Jul 1, 2021N
Withdrawn
- Metastatic NUT Carcinoma
- Unresectable NUT Carcinoma
- Cisplatin
- +4 more
- (no location specified)
2020-09-25
Sep 25, 2020M
Recruiting
- Medulloblastoma Recurrent
- +2 more
- Bevacizumab
- +7 more
- Chicago, Illinois
- +21 more
2022-04-07
Apr 7, 2022Z
Recruiting
- Hemophagocytic Syndrome
- T/NK-Cell Lymphoma
- Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
- Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
2021-08-03
Aug 3, 2021O
Active, not recruiting
- Malignant Glioma
- Carboplatin
- +4 more
- Minneapolis, Minnesota
- +2 more
2021-09-15
Sep 15, 2021S
Recruiting
- Malignant Rhabdoid Tumor
- Atypical Teratoid Rhabdoid Tumor
- alisertib
- +9 more
- Los Angeles, California
- +10 more
2022-03-23
Mar 23, 2022N
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Cytarabine
- +3 more
- Duarte, California
- +6 more
2022-03-31
Mar 31, 2022S
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Azacitidine
- +14 more
- Duarte, California
- +12 more
2022-03-23
Mar 23, 2022S
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
- Palo Alto, California
- +6 more
2022-03-09
Mar 9, 2022C
Completed
- Childhood Favorable Prognosis Hodgkin Lymphoma
- +5 more
- radiation therapy
- +11 more
- Arcadia, CaliforniaChildren's Oncology Group
2021-03-26
Mar 26, 2021M
Unknown status
- Lymphoma
- Radiation Therapy
- +5 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2020-01-21
Jan 21, 2020M
Terminated
- Leukemia
- Clofarabine
- +2 more
- Hershey, PennsylvaniaPenn State Hershey Cancer Institute
2019-07-22
Jul 22, 2019C
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
- Duarte, CaliforniaCity of Hope Medical Center
2021-06-12
Jun 12, 2021H
Completed
- Multiple Myeloma
- Plasma Cell Neoplasm
- etoposide phosphate
- +3 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2019-11-06
Nov 6, 2019C
U
Terminated
- Recurrent Nasopharynx Carcinoma
- Etoposide phosphate
- +3 more
- Gainesville, FloridaUF Health Shands Hospital
2019-05-29
May 29, 2019